# Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin

> **NCT00932165** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 451 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Exemestane

## Key facts

- **NCT ID:** NCT00932165
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 451 (ACTUAL)
- **Last updated:** 2010-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00932165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00932165, "Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00932165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*